Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration

por Gopalakrishnan, Mathangi, Farchione, Tiffany, Mathis, Mitchell, Zhu, Hao, Mehta, Mehul, Uppoor, Ramana, Younis, Islam
Publicado 2020

Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions

por McCracken, James T., Anagnostou, Evdokia, Arango, Celso, Dawson, Geraldine, Farchione, Tiffany, Mantua, Valentina, McPartland, James, Murphy, Declan, Pandina, Gahan, Veenstra-VanderWeele, Jeremy
Publicado 2021